The nation of Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) spanning five years over the United States' insistence on sensitive data.
This move came to light following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesperson later explained that the United States was demanding access to health data for scientific study and commercial purposes while was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for further dialogue to reach a deal agreeable to both sides so the country's vital HIV programme can continue.
Wider Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court blocked a similar health funding agreement after legal challenges were filed about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump stated its spending was "wasteful" and his government was pursuing direct bilateral agreements to boost transparency and accountability.
Based on statements, Sixteen African countries have to date agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment via American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding assurance of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Put simply, our country would provide the raw materials for medical research without any assurance that the final treatments would be available to our citizens should a future disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending systems previously established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.
"This mechanism is designed to guarantee that when a nation provides its data, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the capability to develop them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our American counterparts on how future collaboration could be arranged in a manner that honours the sovereignty and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but suggested that talks need to persist since much of the nation's HIV programmes relied on external financing.
"If technical issues exist, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group added.
The halted deal highlights the continuing challenges between receiving vital international aid and protecting national sovereignty in an ever more data-driven world.